Core Viewpoint - Company successfully completed the qualification supplier registration for its new triazole process product, tazobactam, which is expected to enhance production capacity, reduce production costs, and improve market competitiveness [1] Group 1 - The new triazole process for tazobactam has been successfully registered with downstream customers as a qualified supplier [1] - The expected release of production capacity will not only lower production costs but also increase the selling price of tazobactam [1] - The improvements in production efficiency are anticipated to enhance the company's market competitiveness [1]